Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | MITF | O75030 | 1/20 | 0.58 |
| ▸ | CCR6 | P51684 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | GPR35 | Q9HC97 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | TTR | P02766 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dinitolmide SCHEMBL29360311 | 1.00 | ALDH1A1 (0.68) | ALDH1A1LMNASMN1; SMN2NPSR1HTT | |
| SCHEMBL30597565 | 0.89 | ALDH1A1 (0.61) | ALDH1A1LMNASMN1; SMN2NPSR1HTT | |
| SCHEMBL29697071 | 0.84 | TSHR (0.57) | ALDH1A1LMNASMN1; SMN2NPSR1HTT | |
| SCHEMBL27597666 | 0.84 | ALDH1A1 (0.56) | ALDH1A1LMNASMN1; SMN2NPSR1HTT | |
| SCHEMBL394667 | 0.84 | TSHR (0.57) | ALDH1A1LMNASMN1; SMN2NPSR1HTT | |
| Trinitrotoluene SCHEMBL28549263 | 0.84 | ALDH1A1 (0.55) | ALDH1A1LMNASMN1; SMN2NPSR1HTT | |
| SCHEMBL29975615 | 0.83 | KMT2A (0.53) | ALDH1A1LMNASMN1; SMN2NPSR1HTT | |
| SCHEMBL27860074 | 0.83 | KMT2A (0.53) | ALDH1A1LMNASMN1; SMN2NPSR1HTT | |
| SCHEMBL39367 | 0.83 | ALDH1A1 (0.54) | ALDH1A1LMNASMN1; SMN2NPSR1HTT | |
| SCHEMBL31414427 | 0.83 | ALDH1A1 (0.58) | ALDH1A1LMNASMN1; SMN2NPSR1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12286488-B2 | Anti-dinitolmide monoclonal antibodies and hybridoma cell strain that secretes them | JIANGNAN UNIVERSITY (CN) | 2025-04-29 | — | — | US | claimed |
| WO-2025085377-A1 | USE OF ZOALENE IN LIVESTOCK | ZOETIS SERVICES LLC (US) | 2025-04-24 | — | — | WO | claimed |
| CN-222623682-U | Be used for dinitrate to hold in palm rectifying column for amine reaction | 江苏欧克动物药业有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-114634422-B | Preparation method of dinitolmide | 河北中科金辉药业有限公司 | 2024-07-23 | — | — | CN | claimed |
| CN-117257986-A | Dinitrotolamine solid dispersion and preparation method thereof | 浙江汰泽医药科技有限公司 | 2023-12-22 | — | — | CN | claimed |
| US-20230346879-A1 | COMPOSITIONS AND METHODS FOR COMBINATORIAL DRUG DISCOVERY IN NANOLITER DROPLETS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-11-02 | — | — | US | claimed |
| EP-4232004-A1 | FRACTAL FORMULATIONS | Nanogyre Sprl (BE) | 2023-08-30 | — | — | EP | claimed |
| CN-113624880-B | High-throughput screening method for residual medicines in honey | 深圳海关食品检验检疫技术中心 | 2023-08-04 | — | — | CN | claimed |
| CN-114942289-B | Method for measuring anticoccidial drug in water in surrounding environment of farm by liquid chromatography mass spectrometry | 贵州大学 | 2023-05-16 | — | — | CN | claimed |
| CN-114272215-B | Dinitolmide dry suspension and preparation method thereof | 内蒙古通瑞达生物科技有限公司 | 2023-04-07 | — | — | CN | claimed |
| US-5834473-A | ADMINISTERING BETAINE AS OSMOPROTECTANT WITH A COCCIDIOSTAT, FOR DOMESTIC FOOD ANIMALS, POULTRY | CULTOR, LTD. (FI) | 1998-11-10 | — | — | US | claimed |
| WO-1998032718-A1 | NEW FATTY ACID DERIVATIVES | NORSK HYDRO ASA (NO) | 1998-07-30 | — | — | WO | claimed |
| US-5624678-A | Method and composition for treatment and/or prophylaxis of coccidiosis | FINNFEEDS INTERNATIONAL LIMITED (GB) | 1997-04-29 | — | — | US | claimed |
| EP-0449975-B1 | NON-TIN-BASED, LOW TOXICITY ANTI-FOULING AGENTS | BATTELLE MEMORIAL INSTITUTE (US) | 1997-04-23 | — | — | EP | claimed |
| CN-1141581-A | Compositions for administration to animals with coccidiosis | CULTOR OY (FI) | 1997-01-29 | — | — | CN | claimed |
| EP-0695127-A1 | COMPOSITIONS FOR ADMINISTRATION TO ANIMALS WITH COCCIDIOSIS | Cultor Ltd. (FI) | 1996-02-07 | — | — | EP | claimed |
| EP-0681787-A2 | Use of an enzyme for manufacturing an agent for the treatment and/or prophylaxis of coccidiosis | FINNFEEDS INTERNATIONAL LTD. (GB) | 1995-11-15 | — | — | EP | claimed |
| US-5441743-A | In thermoplastic or thermosetting binder | BATTELLE MEMORIAL INSTITUTE (US) | 1995-08-15 | — | — | US | claimed |
| WO-1994024886-A1 | COMPOSITIONS FOR ADMINISTRATION TO ANIMALS WITH COCCIDIOSIS | CULTOR LTD. (FI) | 1994-11-10 | — | — | WO | claimed |
| WO-1990006975-A1 | NON-TIN-BASED, LOW TOXICITY ANTI-FOULING AGENTS | BATTELLE MEMORIAL INSTITUTE (US) | 1990-06-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346879-A1 | COMPOSITIONS AND METHODS FOR COMBINATORIAL DRUG DISCOVERY IN NANOLITER DROPLETS | RAB5IF, CLTB, TBK1 | ALDH1A1 3381/4885LMNA 3886/4885SMN1; SMN2 3835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.